2013 American Transplant Congress
Pancreas Transplant Outcomes May Be Dependent on Center Experience
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis
Introduction: The number of pancreas transplants (PTx) nationwide is declining, raising concern that some centers may experience low transplant volume; low volume has been associated…2013 American Transplant Congress
Racial Differences and Income Disparities Are Associated with Worse Allograft and Death Outcomes in Kidney Transplant Recipients with Lupus Nephritis
Background: An analysis of income disparities and racial differences on renal transplant outcomes in recipients with lupus nephritis (LN) has not been reported.Methods: We identified…2013 American Transplant Congress
Change of Blood Pressure and Circadian Rhythm after Kidney Transplantation in End Stage Renal Disease Patients, The
BackgroundAfter kidney transplantation (KT), many end-stage renal disease (ESRD) patients showed well controlled blood pressure compared to before KT, but the effect of KT on…2013 American Transplant Congress
Renal Allograft Tolerance Can Be Achieved in Non-Human Primates Via Delayed Mixed-Hematopoietic Chimerism and Alefacept Treatment
Renal allograft tolerance has been achieved in MHC-mismatched NHPs and patients via the mixed-chimerism approach. Activation/expansion of donor-reactive CD8+ effector memory T cells (TEMs) represents…2013 American Transplant Congress
Antagonists of Bone Morphogenetic Protein Signaling Promote Liver Regeneration and Repair in Mice
The Transplant Center and Department of Surgery, Vanderbilt University Medical Center, Nashville, TN
Pharmacologic agents to enhance liver recovery after injury would have wide therapeutic application. Based on previous work suggesting Bone Morphogenetic Protein (BMP) signaling modulates liver…2013 American Transplant Congress
Dual Kidney Transplantation Reduces Organ Wastage and Increases the Number of Kidney Transplants Available to Elderly Candidates
Department of Transplantation, California Pacific Medical Center, San Francisco, CA
Changes in national kidney allocation are anticipated to begin in 2014. The proposed system redefines ECD kidneys, resulting in a reduction in both the quantity…2013 American Transplant Congress
Phase 3, Double-Blind, Multi-Center, Non-Inferiority, Randomized Study To Examine the Efficacy and Safety of LCP-Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil in De Novo Adult Kidney Transplantation: Baseline Characteristics, A
This large, multi-continent, Phase 3, double-blind, randomized, active comparator non-inferiority trial will compare efficacy and safety of a once-daily controlled agglomeration formulation of tacrolimus with…2013 American Transplant Congress
Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 24
HERAKLES Study Group, Germany; Novartis Pharma, Nuremberg, Germany
Aim: To follow up (FU) on the evolution of renal function (RF) of immunosuppressive regimens with different calcineurin inhibitor (CNI) exposure at month (Mo)24 post…2013 American Transplant Congress
Kidney Discard Reasons by Kidney Donor Profile Index (KDPI)
KDPI summarizes the risk of donor kidney graft failure based on clinical and demographic parameters. We hypothesize that discard of a kidney with low KDPI…2013 American Transplant Congress
Single Donor-Derived Strongyloides in Solid Organ Transplants
Geisinger Medical Center, Danville; Temple University Hospital, Philadelphia
CDC was notified of Strongyloides infection in transplant recipients of kidneys, pancreas and heart from same deceased donor. Concern for donor-derived strongyloidiasis prompted an investigation…
- « Previous Page
- 1
- …
- 145
- 146
- 147
- 148
- 149
- …
- 178
- Next Page »